|
Nov 29
|
Health Canada Grants Market Authorization for KALYDECO® (ivacaftor) for Eligible Children With Cystic Fibrosis Ages 2 Months and Older
|
|
Nov 28
|
Arcturus' (ARCT) CF Drug Gets FDA's Orphan Status, Stock Up
|
|
Nov 28
|
Vertex Pharmaceuticals (NASDAQ:VRTX) shareholders have earned a 14% CAGR over the last five years
|
|
Nov 27
|
5 Stocks You Can Confidently Invest $500 In Right Now
|
|
Oct 24
|
The Best Stocks to Invest $5,000 In Right Now
|
|
Oct 23
|
Vertex Pharmaceuticals (VRTX) Increases Despite Market Slip: Here's What You Need to Know
|
|
Oct 23
|
Intellia (NTLA) Focuses on Developing Gene-Editing Therapies
|
|
Oct 22
|
3 Unstoppable Stocks to Buy Sooner Rather Than Later
|
|
Oct 21
|
CRISPR Therapeutics Stock: Bull vs. Bear
|
|
Oct 20
|
12 Cheap Biotech Stocks Smart Investors Are Piling Into
|
|
Oct 20
|
3 Monster Stocks to Buy Without Any Hesitation
|
|
Oct 20
|
Insider Sell: EVP and CMO Carmen Bozic Sells 5,651 Shares of Vertex Pharmaceuticals Inc
|
|
Oct 19
|
GILD or VRTX: Which Is the Better Value Stock Right Now?
|
|
Oct 19
|
4 Ways to Grow $100,000 Into $1 Million for Retirement
|
|
Oct 19
|
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
|
|
Oct 18
|
5 Biotech Stocks Set to Outpace Q3 Earnings Estimates
|
|
Oct 18
|
3 Gene Editing Stocks to Generate Super-Charged Gains
|
|
Sep 12
|
More Likely to 5x First: Bluebird Bio vs. CRISPR Therapeutics
|
|
Sep 10
|
A Bull Market Is (Still) Coming: Here Are 3 Spectacular Stocks to Buy Sooner Rather Than Later
|
|
Sep 9
|
3 Unstoppable Growth Stocks to Buy Right Now
|